Seeing Is Believing
Healthcare - Sector
CTMX is currently covered by 7 analysts with an average price target of $10.33. This is a potential upside of $5.88 (132.13%) from yesterday's end of day stock price of $4.45.
CytomX Therapeutics's activity chart (see below) currently has 106 price targets and 89 ratings on display. The stock rating distribution of CTMX is 93.75% BUY and 6.25% HOLD.
Analysts average stock forecasts to be materialized ratio is 34.16% with an average time for these price targets to be met of 133.75 days.
Highest price target for CTMX is $16, Lowest price target is $10, average price target is $12.5.
Most recent stock forecast was given by ETZER DAROUT from BARCLAYS on 19-Mar-2026.
Currently out of the existing stock ratings of CTMX, 15 are a BUY (93.75%), 1 are a HOLD (6.25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Sep-2025
$16
$11.55 (259.55%)
$10
3 days ago
(19-Mar-2026)
12/19 (63.16%)
$11.22 (234.73%)
290
Buy Since 06-May-2024
$16
$11.55 (259.55%)
$8
4 days ago
(18-Mar-2026)
2/5 (40%)
$11.6 (263.64%)
117
Buy Since 08-Sep-2017
$11
$6.55 (147.19%)
$8
5 days ago
(17-Mar-2026)
4/10 (40%)
$5.55 (101.83%)
133
Hold Since 22-Apr-2024
$12
$7.55 (169.66%)
6 days ago
(16-Mar-2026)
0/3 (0%)
$5.25 (77.78%)
Buy Since 28-May-2024
$10
$5.55 (124.72%)
$5
2 months 2 days ago
(20-Jan-2026)
6/10 (60%)
$4.63 (86.22%)
205
What is CTMX (CytomX Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CTMX (CytomX Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CTMX (CytomX Therapeutics)?
Which analyst is the currently most bullish on CTMX (CytomX Therapeutics)?
Which analyst is the currently most reserved on CTMX (CytomX Therapeutics)?